13G Filing: Rosalind Advisors, Inc. and Zosano Pharma Corp (NASDAQ:ZSAN)

Page 6 of 9 – SEC Filing

         
CUSIP No. 98979H103   13
G/A
  Page
6 of 9 Pages
         

Item
1.

  (a) Name
of Issuer: ZOSANO PHARMA CORPORATION
     
  (b)

Address
of Issuer’s Principal Executive Offices

34790 Ardentech Court

Fremont, CA 94555, United
States

     

Item
2.

 

  (a)

Name
of Person Filing

Rosalind
Advisors, Inc. (“Advisor” to RCP & RMF)

Rosalind
Master Fund L.P. (“RMF”)

Rosalind
Capital Partners L.P. (“RCP”)

Steven
Salamon (“President”)

Steven
Salamon is the portfolio manager of the Advisor which advises RCP & RMF.

     
  (b)

Address
of the Principal Office or, if none, residence
Rosalind Advisors, Inc.

175
Bloor Street East

Suite 1316, North Tower

Toronto,
Ontario

M4W
3R8 Canada

 

Rosalind
Master Fund L.P.

P.O.
Box 309

Ugland
House, Grand Cayman

KY1-1104,
Cayman Islands

 

Rosalind
Capital Partners L.P.

175
Bloor Street East

Suite 1316, North Tower

Toronto,
Ontario

M4W
3R8 Canada

 

Steven
Salamon

175
Bloor Street East

Suite 1316, North Tower

Toronto,
Ontario

M4W
3R8 Canada

     
  (c)

Citizenship
Rosalind Advisors, Inc.: Ontario, Canada

 

Rosalind
Master Fund L.P.: Cayman Islands

Rosalind
Capital Partners L.P.: Ontario, Canada

 

Steven
Salamon: Ontario, Canada

     
  (d) Title of Class
of Securities
Common Stock
     
  (e) CUSIP Number
98979H103

Follow Zosano Pharma Corp (NASDAQ:ZSAN)